{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:29:58Z","timestamp":1792002598243,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013726","name":"The Abraham J & Phyllis Katz Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011621","name":"Emory University Winship Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016531","name":"Integrated Cellular Imaging Core, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.canlet.2025.217855","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:59:28Z","timestamp":1749157168000},"page":"217855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis"],"prefix":"10.1016","volume":"628","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4225-3969","authenticated-orcid":false,"given":"Wenxi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3393-8161","authenticated-orcid":false,"given":"Tenzin","family":"Passang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9307-3400","authenticated-orcid":false,"given":"Shayna E.","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chih","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6132-7847","authenticated-orcid":false,"given":"Zihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8787-7678","authenticated-orcid":false,"given":"Gregory B.","family":"Lesinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia R.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia R.","family":"Giver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans E.","family":"Grossniklaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0816-6729","authenticated-orcid":false,"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217855_bib1","series-title":"Cancer Facts & Figures 2023","author":"Society","year":"2023"},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","article-title":"Metastatic pathways and time courses in the orderly progression of cutaneous melanoma","volume":"147","author":"Meier","year":"2002","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217855_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/annonc\/mdw694","article-title":"The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients","volume":"28","author":"Lian","year":"2017","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217855_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jso.20079","article-title":"The natural course of cutaneous melanoma","volume":"86","author":"Leiter","year":"2004","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jid.2020.03.943","article-title":"Treatment of advanced melanoma in 2020 and beyond","volume":"141","author":"Jenkins","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217855_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ctrv.2012.01.002","article-title":"Uveal melanoma","volume":"38","author":"Spagnolo","year":"2012","journal-title":"Cancer Treat Rev."},{"issue":"15","key":"10.1016\/j.canlet.2025.217855_bib7","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: from diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.canlet.2025.217855_bib10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jso.23535","article-title":"The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection","volume":"109","author":"Gomez","year":"2014","journal-title":"J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/cncr.28480","article-title":"Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options","volume":"120","author":"Agarwala","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib13","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1038\/s41467-022-34242-4","article-title":"Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Ravindranathan","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2025.217855_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/bloodadvances.2017011254","article-title":"Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kdelta inhibitors and VIP antagonists","volume":"2","author":"Petersen","year":"2018","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01228307","article-title":"The location of VIP in the pancreas of man and rat","volume":"18","author":"Bishop","year":"1980","journal-title":"Diabetologia (Berl.)"},{"issue":"4 Pt 1","key":"10.1016\/j.canlet.2025.217855_bib17","first-page":"1242","article-title":"Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease","volume":"102","author":"Kubota","year":"1992","journal-title":"Gastroenterology (New York, N. Y., 1943)"},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2025.217855_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000125795","article-title":"Vasoactive intestinal peptide in the hypothalamus and pituitary","volume":"53","author":"Lam","year":"1991","journal-title":"Neuroendocrinology (Basel)"},{"issue":"3","key":"10.1016\/j.canlet.2025.217855_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0065-1281(97)80024-4","article-title":"Immunohistochemical detection of human skin nerve fibers","volume":"99","author":"Schulze","year":"1997","journal-title":"Acta Histochem."},{"issue":"4","key":"10.1016\/j.canlet.2025.217855_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/1523-1747.ep12519966","article-title":"Immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in Merkel cells of various mammals: evidence for a neuromodulator function of the Merkel cell","volume":"81","author":"Hartschuh","year":"1983","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217855_bib21","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1167\/iovs.07-1543","article-title":"VIP and VIP gene silencing modulation of differentiation marker N-cadherin and cell shape of corneal endothelium in human corneas ex vivo","volume":"49","author":"Koh","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2025.217855_bib22","first-page":"592","article-title":"Species differences in choroidal vasodilative innervation: evidence for specific intrinsic nitrergic and VIP-positive neurons in the human eye","volume":"35","author":"Flugel","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.canlet.2025.217855_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.preteyeres.2009.06.002","article-title":"Immune escape mechanisms of intraocular tumors","volume":"28","author":"Niederkorn","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00726-011-1184-8","article-title":"Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions","volume":"45","author":"Delgado","year":"2013","journal-title":"Amino Acids"},{"issue":"4","key":"10.1016\/j.canlet.2025.217855_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0896-6273(92)90101-I","article-title":"Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide","volume":"8","author":"Ishihara","year":"1992","journal-title":"Neuron (Camb., Mass.)"},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib26","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1210\/endo.135.6.7988457","article-title":"Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions","volume":"135","author":"Usdin","year":"1994","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.canlet.2025.217855_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-5728(96)00063-X","article-title":"Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes","volume":"68","author":"Delgado","year":"1996","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1530\/EC-14-0051","article-title":"VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235","volume":"4","author":"Schulz","year":"2015","journal-title":"Endocr Connect"},{"key":"10.1016\/j.canlet.2025.217855_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2000.tb06950.x","article-title":"Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes","volume":"921","author":"Lara-Marquez","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.canlet.2025.217855_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121880","article-title":"The neuropeptide VIP limits human osteoclastogenesis: clinical associations with bone metabolism markers in patients with early arthritis","volume":"9","author":"Castro-Vazquez","year":"2021","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.canlet.2025.217855_bib31","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/0008-5472.CAN-23-3628","article-title":"VPAC2 receptor signaling promotes growth and immunosuppression in pancreatic cancer","volume":"84","author":"Passang","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MED.0000000000000218","article-title":"Vasoactive intestinal peptide\/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer","volume":"23","author":"Moody","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"3","key":"10.1016\/j.canlet.2025.217855_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1385\/JMN:17:3:331","article-title":"A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells","volume":"17","author":"Sharma","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.canlet.2025.217855_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.170940","article-title":"Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway","volume":"161","author":"Asano","year":"2023","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.226","article-title":"Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling","volume":"8","author":"Sastry","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217855_bib36","first-page":"T5","article-title":"Uveal melanoma cell lines: where do they come from? (An American ophthalmological society thesis)","volume":"114","author":"Jager","year":"2016","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"1\u20136","key":"10.1016\/j.canlet.2025.217855_bib37","first-page":"349","article-title":"Murine models of liver metastasis","volume":"14","author":"Rusciano","year":"1994","journal-title":"Invasion Metastasis"},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btac757","article-title":"GSEApy: a comprehensive package for performing gene set enrichment analysis in Python","volume":"39","author":"Fang","year":"2023","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.canlet.2025.217855_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1076\/ceyr.18.2.125.5380","article-title":"B16LS9 melanoma cells spread to the liver from the murine ocular posterior compartment (PC)","volume":"18","author":"Diaz","year":"1999","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217855_bib40","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.18632\/oncotarget.6500","article-title":"The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib41","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1167\/iovs.09-4755","article-title":"Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma","volume":"51","author":"Yang","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2025.217855_bib42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data Resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.canlet.2025.217855_bib43","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.canlet.2025.217855_bib44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1101\/gad.296962.117","article-title":"Focus on cutaneous and uveal melanoma specificities","volume":"31","author":"Pandiani","year":"2017","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060845","article-title":"Uveal versus cutaneous melanoma; same origin, very distinct tumor types","volume":"11","author":"van der Kooij","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib46","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/(SICI)1097-0215(19990611)81:6<951::AID-IJC18>3.0.CO;2-V","article-title":"Influence of MUC18\/MCAM\/CD146 expression on human melanoma growth and metastasis in SCID mice","volume":"81","author":"Schlagbauer-Wadl","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217855_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2012.11.049","article-title":"CD146, a multi-functional molecule beyond adhesion","volume":"330","author":"Wang","year":"2013","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2025.217855_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12935-014-0147-z","article-title":"The multifaceted role of CD146\/MCAM in the promotion of melanoma progression","volume":"15","author":"Lei","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.canlet.2025.217855_bib49","first-page":"3819","article-title":"N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells","volume":"61","author":"Li","year":"2001","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2025.217855_bib50","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1002\/jcp.30402","article-title":"Vimentin affects colorectal cancer proliferation, invasion, and migration via regulated by activator protein 1","volume":"236","author":"Wang","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217855_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/path.1416","article-title":"Integrins in regulation of tissue development and function","volume":"200","author":"Danen","year":"2003","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217855_bib52","first-page":"2218","article-title":"Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18\/MCAM","volume":"56","author":"Rummel","year":"1996","journal-title":"Cancer Res."},{"issue":"47","key":"10.1016\/j.canlet.2025.217855_bib53","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1038\/onc.2015.36","article-title":"The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma","volume":"34","author":"Wang","year":"2015","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.canlet.2025.217855_bib54","doi-asserted-by":"crossref","first-page":"G263","DOI":"10.1152\/ajpgi.00275.2018","article-title":"Cyclic AMP-dependent protein kinase A and EPAC mediate VIP and secretin stimulation of PAK4 and activation of Na(+),K(+)-ATPase in pancreatic acinar cells","volume":"316","author":"Ramos-Alvarez","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"47","key":"10.1016\/j.canlet.2025.217855_bib55","doi-asserted-by":"crossref","first-page":"31427","DOI":"10.1074\/jbc.273.47.31427","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein\/c-Jun","volume":"273","author":"Delgado","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.canlet.2025.217855_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0309-1651(06)80111-6","article-title":"VIP stimulates proliferation and differentiation of the cultured retinal pigment epithelium with disparate potencies","volume":"16","author":"Koh","year":"1992","journal-title":"Cell Biol. Int. Rep."},{"issue":"4","key":"10.1016\/j.canlet.2025.217855_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0092-8674(02)00736-5","article-title":"The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei","volume":"109","author":"Harmar","year":"2002","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.canlet.2025.217855_bib58","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MPA.0b013e318214c783","article-title":"Characterization of intestinal and pancreatic dysfunction in VPAC1-null mutant mouse","volume":"40","author":"Fabricius","year":"2011","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.canlet.2025.217855_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036922","article-title":"VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses","volume":"7","author":"Abad","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217855_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.852358","article-title":"Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migration","volume":"12","author":"Asano","year":"2022","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2025.217855_bib61","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1158\/0008-5472.CAN-16-0427","article-title":"Modulation of immune checkpoints and graft-versus-leukemia in allogeneic transplants by antagonizing vasoactive intestinal peptide signaling","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525004227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525004227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:35:39Z","timestamp":1762288539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525004227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":60,"alternative-id":["S0304383525004227"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217855","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217855"}}